Afuco™ Anti-Human HGF ADCC Therapeutic Antibody (TAK-701), ADCC Enhanced
Anti-HGF ADCC Enhanced Antibody (TAK-701) is an ADCC enhanced antibody produced by our Afuco™ platform. TAK-701 is a humanized monoclonal antibody to hepatocyte growth factor, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-335CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | HGF |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4 °C, -20°C if preferred |